No need for skin and in vitro tests in most children with suspected allergy to beta‐lactam antibiotics

1. Hsiao KC, Smart J. Anaphylaxis caused by in-season switchover of sublingual immunotherapy formulation. Pediatr Allergy Immunol 2014: Sep 9. doi:10.1111/ pai.12268. 2. Lyseng-Williamson KA. Sublingual fivegrass pollen tablets (Oralair ): a guide to their use as allergen immunotherapy for grass pollen-induced allergic rhinoconjunctivitis. Drugs & Therapy Perspectives 2014: 30: 200–208. 3. Didier A, Wahn U, Horak F, Cox LS. Fivegrass-pollen sublingual immunotherapy tablet for the treatment of grass-polleninduced allergic rhinoconjunctivitis: 5 years of experience. Expert Rev Clin Immunol 2014: 10: 1309–24. 4. Canonica GW, Cox L, Pawankar R, et al. Sublingual immunotherapy: world Allergy Organization position paper 2013 update. World Allergy Organ J 2014: 7: 6. 5. Oralair Sublingual Tablets: Food And Drug Administration Allergenic Products Advisory Committee briefing document. Antony: Stallergenes S.A., 2013.